NCAM1 and acute lymphoblastic leukemia: In 2013, Gimenes-Teixeira found that miR-221 and miR-374 were expressed at significantly higher levels in CD56+ T-ALL than in CD56- T-ALL, and in leukemic blasts compared to normal thymocytes and normal T cells.